[Video] I told Akrobeto not to act with Agya Koo – Miracle Films CEO confirms
By CornerGist (self media writer) | 8 months ago
Actor, the comedian, and TV host Akwasi Boadi, also known by his stage name Akrobeto, is from Ghana. He is well-known for the size of his nose and has appeared in more than 100 Kumawood films. In the entertainment world, Akwesi Boadi is referred to as Akrobeto (who "noses" tomorrow).
The CEO of Miracle Films, Samuel Nyamekye, has admitted giving Akrobeto the order not to collaborate with Agya Koo. Akrobeto previously admitted to Peace FM that the renowned director had advised him not to collaborate with Agya Koo. Mr. Nyamekye stated as much in an interview with ZionFelix.
He stated that it was part of his strategy to make Akrobeto more well-known. According to the head of Miracle Films, Agya Koo used the same strategy to become a well-known name in the film industry.
He asserted that Nana Ama McBrown and Emelia Brobbey had comparable treatment.
The interview is below.
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our PlatformSee More
COMMENTS